This week on #ThePalveshow, my guest is Jessica Tracy. Jessica and I speak about her journey from prescription medications that did little to help, to finding permanent healing through psychedelics.
Jessica also shares the importance of #psychedelic assisted therapy and the future of psychedelic #healthcare.
#Palveshow #PsychedelicHealthcare #NaturalMedicine
_____
Jessica Tracy is the CEO and Founder of The Sage Collective, a purpose-led consulting company whose mission is to integrate psychedelic assisted therapy into the current health ecosystem so that more patients can have access to safe and affordable care. We do this by supporting companies, payors/TPAs and health systems in the strategic planning and implementation of these therapies and in doing so, we help bridge the gap between psychedelics, business, insurance and the healthcare ecosystem.
Jessica brings over 16 years of diverse healthcare experience in data analytics, strategic advisory and consulting, business development and go to market strategy. Her work spans across healthcare ranging from group insurance, clinical genetics and diagnostics, healthcare technology and psychedelic assisted therapies. Jessica began her career in underwriting and data analytics then led sales and consulting partnerships developing health insurance strategies for large employers, unions and public sector clients before transitioning to healthcare technology where she helped employers, unions, payors and health systems implement innovative delivery models for hard to access care, such as clinical genetics.
Jessica's passion is on increasing awareness and access to psychedelic assisted psychotherapies. She has provided strategic advisory for ketamine clinics and is a member of the Ketamine Task Force whose objective is to increase insurance coverage and FDA approval for these therapies through clinical research. Through The Sage Collective, Jessica provides strategic advisory for the application of psychedelic assisted psychotherapies (PAP), including work with Enthea - a third party administrator of ketamine and psychedelic assisted psychotherapies, a health system where she is leading their efforts to integrate neuromodulatory treatments, ketamine assisted psychotherapies and psychedelic assisted psychotherapies into treatment and clinical research protocols and other partners. She has completed various clinical certifications in psychedelics including Essential Contemplative Practices of a Psychedelic Therapists, Introduction to Psychedelic Therapies, and Psychedelic Facilitator Training.
thesagecollective.co
